Outcomes in randomized controlled trials of therapeutic interventions for multiple myeloma: A systematic review.
Saved in:
| Title: | Outcomes in randomized controlled trials of therapeutic interventions for multiple myeloma: A systematic review. |
|---|---|
| Authors: | Mainou M; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece. Electronic address: mfcmary@hotmail.com., Tsapa K; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece., Michailidis T; First Department of Internal Medicine, AHEPA General Hospital, Aristotle University of Thessaloniki, Greece., Malandris K; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece., Karagiannis T; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece., Avgerinos I; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece., Liakos A; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece., Papaioannou M; Hematology Unit, First Department of Internal Medicine, AHEPA General Hospital, Aristotle University of Thessaloniki, Greece., Terpos E; National and Kapodistrian University of Athens - Faculty of Medicine, Department of Clinical Therapeutics, Plasma Cell Dyscrasias Unit, Alexandra General Hospital, Athens, Greece., Prasad V; University of California San Francisco, Department of Epidemiology and Biostatistics, San Francisco, CA, USA., Tsapas A; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece; Harris Manchester College, University of Oxford, Oxford, UK. |
| Source: | Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2024 Dec; Vol. 204, pp. 104529. Date of Electronic Publication: 2024 Oct 04. |
| Publication Type: | Systematic Review; Journal Article |
| Journal Info: | Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39368634 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Outcomes in randomized controlled trials of therapeutic interventions for multiple myeloma: A systematic review. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mainou+M%22">Mainou M</searchLink>; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece. Electronic address: mfcmary@hotmail.com.<br /><searchLink fieldCode="AU" term="%22Tsapa+K%22">Tsapa K</searchLink>; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Michailidis+T%22">Michailidis T</searchLink>; First Department of Internal Medicine, AHEPA General Hospital, Aristotle University of Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Malandris+K%22">Malandris K</searchLink>; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Karagiannis+T%22">Karagiannis T</searchLink>; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Avgerinos+I%22">Avgerinos I</searchLink>; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Liakos+A%22">Liakos A</searchLink>; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Papaioannou+M%22">Papaioannou M</searchLink>; Hematology Unit, First Department of Internal Medicine, AHEPA General Hospital, Aristotle University of Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Terpos+E%22">Terpos E</searchLink>; National and Kapodistrian University of Athens - Faculty of Medicine, Department of Clinical Therapeutics, Plasma Cell Dyscrasias Unit, Alexandra General Hospital, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Prasad+V%22">Prasad V</searchLink>; University of California San Francisco, Department of Epidemiology and Biostatistics, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Tsapas+A%22">Tsapas A</searchLink>; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece; Harris Manchester College, University of Oxford, Oxford, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228916049%22">Critical reviews in oncology/hematology</searchLink> [Crit Rev Oncol Hematol] 2024 Dec; Vol. 204, pp. 104529. <i>Date of Electronic Publication: </i>2024 Oct 04. – Name: TypePub Label: Publication Type Group: TypPub Data: Systematic Review; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Scientific+Publishers%22">Elsevier Scientific Publishers </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8916049 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0461 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210408428%22">10408428 </searchLink><i>NLM ISO Abbreviation: </i>Crit Rev Oncol Hematol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39368634 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.critrevonc.2024.104529 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 104529 Titles: – TitleFull: Outcomes in randomized controlled trials of therapeutic interventions for multiple myeloma: A systematic review. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mainou M – PersonEntity: Name: NameFull: Tsapa K – PersonEntity: Name: NameFull: Michailidis T – PersonEntity: Name: NameFull: Malandris K – PersonEntity: Name: NameFull: Karagiannis T – PersonEntity: Name: NameFull: Avgerinos I – PersonEntity: Name: NameFull: Liakos A – PersonEntity: Name: NameFull: Papaioannou M – PersonEntity: Name: NameFull: Terpos E – PersonEntity: Name: NameFull: Prasad V – PersonEntity: Name: NameFull: Tsapas A IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2024 Dec Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1879-0461 Numbering: – Type: volume Value: 204 Titles: – TitleFull: Critical reviews in oncology/hematology Type: main |
| ResultId | 1 |